Literature DB >> 1727814

Decreased insulin clearance as a feature of essential hypertension.

T Salvatore1, D Cozzolino, R Giunta, D Giugliano, R Torella, F D'Onofrio.   

Abstract

Several studies report that essential hypertension is associated with hyperinsulinemia. This condition may depend on enhanced pancreatic insulin secretion and/or a decreased MCR of the circulating hormone. Twenty-five nonobese glucose-normotolerant patients with primary hypertension were divided into 5 groups, each consisting of 5 subjects. Each group was submitted to continuous 120-min double infusion of different doses of insulin (group I, 0.025; II, 0.05; III, 0.1; IV, 0.2; V, 0.4 U/kg.h) and glucose (I, 2; II, 3.5; III, 6; IV, 8; V, 10 mg/kg.min). The same procedures were applied to 25 healthy normotensive volunteers. Basal and steady state plasma levels of glucose, insulin, and C-peptide were significantly (P less than 0.05 or less) higher in hypertensive patients than in control subjects of all groups. The MCR of insulin (milliliters per kg/min) at all insulin-glucose infusion rates was significantly (P less than 0.05 or less) lower in hypertensive than normotensive subjects. Despite the significantly higher steady state plasma insulin levels in hypertensives, the MCR of glucose (milliliters per kg/min) was significantly (P less than 0.05 or less) lower in hypertensive than normotensive subjects. These results suggest that an altered insulin removal may contribute to the hyperinsulinemia found in the essential hypertensive subjects. In addition, a defect in insulin-stimulated glucose uptake which persists at supraphysiological insulin concentrations is confirmed in this population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727814     DOI: 10.1210/jcem.74.1.1727814

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress.

Authors:  A Ceriello; A Quatraro; D Giugliano
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

2.  Particulate and ion forms of cobalt-chromium challenged preosteoblasts promote osteoclastogenesis and osteolysis in a murine model of prosthesis failure.

Authors:  Shuye Yang; Kai Zhang; Jianhao Jiang; Bonface James; Shang-You Yang
Journal:  J Biomed Mater Res A       Date:  2018-10-25       Impact factor: 4.396

3.  Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?

Authors:  D Giugliano; A Quatraro; A Minei; N De Rosa; L Coppola; F D'Onofrio
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

4.  Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.

Authors:  C C Lee; C Lorenzo; S M Haffner; L E Wagenknecht; M O Goodarzi; D Stefanovski; J M Norris; M J Rewers; A J Hanley
Journal:  Diabetes Obes Metab       Date:  2013-01-21       Impact factor: 6.577

5.  Correlates of insulin clearance in apparently healthy non-obese Japanese men.

Authors:  Hideyoshi Kaga; Yoshifumi Tamura; Kageumi Takeno; Saori Kakehi; Takashi Funayama; Yasuhiko Furukawa; Miho Nishitani-Yokoyama; Kazunori Shimada; Hiroyuki Daida; Shigeki Aoki; Adria Giacca; Akio Kanazawa; Ryuzo Kawamori; Hirotaka Watada
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

6.  Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study.

Authors:  C Christine Lee; Steven M Haffner; Lynne E Wagenknecht; Carlos Lorenzo; Jill M Norris; Richard N Bergman; Darko Stefanovski; Andrea M Anderson; Jerome I Rotter; Mark O Goodarzi; Anthony J Hanley
Journal:  Diabetes Care       Date:  2012-12-05       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.